Bone and mineral abnormalities in childhood acute lymphoblastic leukemia: influence of disease, drugs and nutrition

International Journal of Cancer

Volumn 78, Issue SUPPL. 11, 1998, Pages 35-39

  Atkinson, Stephanie A ^a   Halton, Jacquelim ^b   Bradley, Cristine ^a   Wu, Binky ^a   Barr, Ronald D ^c  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON HEALTH SCIENCES   (Canada)

^c CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CALCITRIOL; DEXAMETHASONE; MAGNESIUM; MINERAL; OSTEOCALCIN; PARATHYROID HORMONE; PREDNISONE; STEROID; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; BIOLOGICAL MARKER; GLUCOCORTICOID; VITAMIN D;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; BONE TURNOVER; CANCER CHEMOTHERAPY; CHILD; CHILD NUTRITION; CHILDHOOD LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEBRILE NEUTROPENIA; FEMALE; FRACTURE; HUMAN; HYPERCALCIURIA; HYPOMAGNESEMIA; INFANT; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA REMISSION; MAGNESIUM URINE LEVEL; MALE; METABOLIC BONE DISEASE; OSTEOPENIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VITAMIN D METABOLISM; ACUTE LYMPHOCYTIC LEUKEMIA; ARTICLE; BLOOD; BONE; BONE DENSITY; METABOLISM; NUTRITION; PRESCHOOL CHILD; PROSPECTIVE STUDY;

ADOLESCENT; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; BIOLOGICAL MARKERS; BONE AND BONES; BONE DENSITY; BONE DISEASES, METABOLIC; CHILD; CHILD, PRESCHOOL; FEMALE; GLUCOCORTICOIDS; HUMANS; INFANT; LEUKEMIA, LYMPHOCYTIC, ACUTE; MAGNESIUM; MALE; NUTRITION PHYSIOLOGY; PROSPECTIVE STUDIES; VITAMIN D;

EID: 0032245769     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(1998)78:11+<35::aid-ijc11>3.0.co;2-i     Document Type: Article

References (19)

1. ATKINSON, S.A., FRAHER, L., GUNDBERO, CM., ANDREW, M., PAI, M. and BARR, R.D., Mineral homeostasis and bone mass in children treated for acute lymphoblastic leukemia. J. Pediatr., 114,793-800 (1989).
2. ATKINSON, S.A., HALTON, J.M., HAY, J., GORDON, C. and WEBBER, C.E., Normative values for lumbar spine bone mass in children in relation to age, gender, dietary intake and physical activity. J. Bone Min. Res., 6 (Suppl.), A196(1991).
3. BAR, R.S., WILSON, U.E. and MAZZAFERRI, E.L., Hypomagnesemic hypocalcemia secondary to renal magnesium wasting: a possible consequence of high dose gentamicin therapy. Ann. int. Med., 82,646-649 ( 1975).
4. BILLETT, A.L., GELBER, R.D., TARBELL, N.J., DALTON, V., DONNELLY, M. and SALLAN, S.E., Results of Dana-Farber Cancer Institute-Consortium childhood acute lymphoblastic leukemia protocols. Int. J. pedialr. HematoU Oncol, 5,115-123(1998).
5. DURLACH, J., Secondary magnesium deficits. In J. Durlach (ed.), Magnesium in clinical practice, pp. 111-194, J. Libbey, London (1988).
6. GERLACH, K., MOROWITZ, D.A. and KIRSNER, J.B., Symptomatic hypomagnesemia complicating regional enteritis. Gastwenterology, 59, 567-574 (1970).
7. GHAZALI, S. and BARRAT, T.M., Urinary excretion of calcium and magnesium in children. Arch. Dis. Child., 49,97-101 (1974).
8. HAHN, T.J., Steroid and drug induced osteopenia In M.J. Favus (ed.), Primer on the metabolic bone diseases and disorders of mineral metabolism, Society for Bone and Mineral Research, Kelseyville, CA(1990).
9. HALTON, J.M., ATKINSON, S.A., FRAHER, L., WEBBER, C., GILL, G.J., DAWSON, S. and BARR, R.D., Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia. J. Bone Min. Res., 11,1774-1783(1996).
10. HALTON, J.M., ATKINSON, S.A., FRAHER, L., WEBBER, C.E., COCKSHOTT, W.P., TAM, C. and BARR, R.D., Mineral homeostasis and bone mass at diagnosis in children with acute lymphoblastic leukemia. J. Pediatr., 126, 557-564(1995).
11. HEALTH AND WELFARE CANADA, Health Protection Branch, Nutrition recommendations. Canadian Government Publishing Centre, Ottawa (1990).
12. HESSELING, P.D., HOUGH, S.F., NEL, E.D., VAN RIET, F.A., BENEKE, T. and WESSELS, G., Bone mineral density in long term survivors of childhood cancer. Int. J. Cancer, Suppl. 11, XX-XX (1998).
13. LASALA, M., LIFSHITZ, F., SILVERBERG, M., WAPNIR, R.A. and CARRERA, E., Magnesium metabolism studies in children with chronic inflammatory disease of the bowel. J. pediatr. Gastroenterol. Nutr., 4,75-81 ( 1985).
14. LUKERT, B.P. and RAISZ, L.G., Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann. int. Med., 112,352-364 (1990).
15. MORRISON, N.A., SHINE, J., GRAGONAS, J.-C., VERKEST, V., MCMENEMY, M.L. and EISMAN, J.A., 1,25-Dihydroxy vitamin D-responsive element and glucocorticoid repression in the osteocalcin gene. Science, 246, 1158-1161 (1989).
16. NYSOM, K., MOLGAARD, C., HOLM, K., HERTZ, H. and FLEISCHER MICHAELSEN, K., Bone mass and body composition after cessation of therapy for childhood cancer. Int. J. Cancer, Suppl. 11, XX-XX (1998).
17. WOLTHERS, O.D., RIIS, B.J. and PEDERSEN, S., Bone turnover in asthmatic children treated with oral prednisolone or inhaled budesonide. Pediatr. Pulmonol. 16,341-346 (1993).
18. WU, B., Hypomagnesemia in children treated for acute lymphoblastic leukemia: investigation of etiology and relationship to altered bone metabolism. Master of Sciences thesis, McMaster University, Hamilton, Ontario, Canada (1994).
19. WU, B., ATKINSON, S.A., HALTON, J.M. and BARR, R.D., Hypermagnesuria and hypercalciuria in childhood leukemia: an additive effect of amikacin therapy. J. pediatr. IlematoUOncol, 18,86-89 (1996).